Innoplexus - a Partex Company

Innoplexus, founded in 2011, leverages Artificial intelligence, machine learning, and blockchain to revolutionize life sciences. With a portfolio of 190+ US/EU patents, it aggregates and analyzes biomedical data to aid drug discovery, optimize clinical trials, and ensure regulatory compliance. By leveraging its ontology, data and AI models, it accelerates drug development and reduces costs. Committed to innovation and collaboration, it empowers Big Pharma and CROs to bring effective treatments to market efficiently and faster. It is headquartered in Eschborn, Germany, with offices in Pune, India, Iselin and San Francisco, USA

Innovation management,bigdata & analytics,machine learning,network analysis,text analytics,artificial intelligence,natural language processing,computer vision,topical deep web crawling,network analysis,ontologies,entity normalization,kol discovery,continuous analytics,blockchain,and biomarker

Innoplexus - a partex company operates in the It services and it consulting industry.

Innoplexus - a partex company's revenue is 11m - 100m

Innoplexus - a partex company has 201 - 500 employees.